Company profile
Tagomics Ltd is a UK company with status active founded in 2020 based in West Midlands.
Financial period: 1 Aug 2023 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
Tagomics develops a cancer diagnosis method using blood tests.
Tagomics is a biotechnology company focussed on the development of new tests for the early-stage detection of cancers.
Tagomics currently has three full-time employees, two of whom are scientists.
1 May 2025 to 30 Apr 2027
**Healthcare Challenge** Colorectal cancer (CRC) is a major health concern in the UK, with more than 44,100 people diagnosed every year. Early detection is crucial, as survival rates are significantly higher when cancer is caught in the early stages---90% at Stage I, compared to just 15% at Stage IV. Despite this, over 60% of CRC cases are diagnosed at ad...
1 May 2021 to 31 Jul 2022
Cancer is a growing concern globally, with cases set to rise to 21.6M by 2030 (American Cancer Society) with a cost of $458B. Cancer cases in the UK alone are set to rise to 514,000 cases per year by 3035 and the cost of care is predicted to be £15.3B in 2021 alone (NHS). Cancer also has a significant economic expense of around £7.6B per year in the UK, w...
